Eight Roads Ventures
Eight Roads Ventures is a global venture capital firm and the proprietary investment arm of Fidelity International Limited (FIL). It targets technology-enabled companies across stages from early venture to growth and late-stage, with a focus on healthcare IT, information technology, software and services, fintech, consumer and enterprise technology, telecommunications, and related sectors. It operates internationally with offices in Europe (London) and Asia (Beijing, Shanghai, Hong Kong, Tokyo, Mumbai, Bengaluru) and partnerships in Israel, Singapore, and the United States, reflecting a broad geographic scope. It typically invests between modest seven-figures to tens of millions of dollars, seeks to lead or co-lead and often takes a board seat, supporting portfolio companies with strategic and operational expertise. The firm emphasizes long-standing partnerships and a hands-on approach, backed by FIL’s resources.
Top Stages
582 past transactions
UGOKU
Series B in 2025
UGOKU is a provider of management of personal coaching service.
Salowin
Series D in 2025
Salowin Inc., established in 2019 and headquartered in Tokyo, Japan, operates a unique business model within the beauty industry. The company provides a share salon concept for beauticians, offering private rooms equipped with well-maintained facilities. Salowin supports its tenants through services such as prepayment systems for sales and comprehensive support, enabling beauticians to focus on their craft while benefiting from shared resources and increased income potential.
Swan
Series B in 2025
Swan is a Paris-based fintech company founded in 2019 that specializes in embedded finance through its Banking-as-a-Service platform. It enables businesses to create and manage bank accounts, issue cards, and generate IBANs seamlessly using straightforward APIs. Serving more than 60 clients across ten European countries, Swan handles over 200 million euros in transactions monthly. The company is staffed by over 100 employees, led by experts in the fintech sector. As a licensed financial institution regulated by the ACPR, Swan operates as a principal member of Mastercard, positioning itself as a key player in the European financial technology landscape.
Eleos Health
Series C in 2025
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.
Beads
Series A in 2025
Beads is a dedicated operator of hospice housing facilities, specializing in providing end-of-life care for patients with terminal cancer or intractable neurological diseases. The company offers a residential setting that combines nursing care and palliative support, aiming to create a comfortable and dignified environment for patients to spend their final days.
Tenpoint Therapeutics
Venture Round in 2024
Tenpoint Therapeutics is a biotechnology company dedicated to developing engineered cell-based therapies aimed at restoring vision for individuals affected by degenerative ocular diseases. The company leverages an innovative platform that includes in vivo reprogramming techniques, allowing for targeted delivery of therapeutic systems directly to the eye. This approach eliminates the need for systemic administration, which can improve treatment efficacy and patient outcomes. By focusing on vision restoration, Tenpoint Therapeutics strives to significantly enhance the quality of life for patients suffering from various eye conditions.
Laurus Bio
Venture Round in 2024
Laurus Bio specializes in precision fermentation services, focusing on microbial fermentation-based manufacturing and product development. They produce animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements, catering to industries such as cultured meat, biologics manufacturing, vaccines, stem cells, and regenerative medicine.
Lighthouse
Series C in 2024
Lighthouse is a commercial platform tailored for the travel and hospitality industry, specializing in hotel management solutions. The company offers a cloud-based platform that visualizes and leverages data to enhance business success. By providing actionable market insights and business intelligence tools, Lighthouse enables hoteliers and hotel management companies to make informed revenue and distribution decisions. Its services include real-time data analytics, which empower users to maximize property occupancy rates and increase revenue and profit. Formerly known as OTA Insight, Lighthouse aims to transform complex market dynamics into manageable strategies that foster growth in the hospitality sector.
Bhanzu
Series B in 2024
Bhanzu is a learning platform focused on mathematics education. It caters to students of all ages and grades, offering personalized learning experiences tailored to individual needs. The platform aims to foster careers in math and STEM fields by providing engaging educational content, including videos with tips on overcoming math anxiety for young learners.
Dingzhi Dental
Series A in 2024
Dingzhi Dental is a comprehensive dental service provider, offering a wide array of oral health services including dental implants, orthodontics, aesthetic restoration, periodontal treatment, pediatric dentistry, and general dentistry. The company specializes in dental medical chain management, institutional investment, medical education, and supply chain services, as well as dental institution franchising and discipline co-construction.
AvenCell
Series B in 2024
Based on our deep science and focused on patients in need.
Everstage
Series B in 2024
Everstage is a no-code commissions automation platform founded in 2020 and based in Wilmington, Delaware. The company specializes in providing tools that streamline and enhance the management of sales commissions for customer-facing teams. Its platform offers real-time visibility and insights into performance, allowing businesses to create customized incentive structures while automating repetitive manual tasks. By delivering a transparent and gamified experience, Everstage helps organizations motivate their teams and improve overall performance.
Spry
Series B in 2024
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.
Fat Fee
Series A in 2024
Fat Fee is a health food supplier, mainly engaged in the healthy upgrading of oils and the development and application of fat replacement technology based on bio-oil refining technology, and has launched a series of edible oil products.
HERO Software
Series B in 2024
HERO Software provides cloud-based solutions aimed at enhancing office efficiency through digitization. Their platform enables companies to streamline their project management processes from initial contact through implementation and invoicing. Key features of the HERO app include customer and project management, appointment scheduling, construction site documentation, and task management, all designed to support field operations and client visits. The software helps businesses manage the entire order-processing cycle, monitor project progress, and handle planning and invoicing, ultimately improving communication and operational efficiency.
Canoe
Series C in 2024
Canoe Software Inc. provides a sophisticated software solution focused on financial document and data management. Founded in 2013 and based in New York, the company specializes in automating the extraction and organization of investment documents using artificial intelligence and machine learning technologies. This enables users to efficiently convert unstructured data from various formats, such as PDFs, into actionable insights, thereby improving operational efficiency. Canoe's platform supports a wide range of clients, including single and multi-family offices, endowments, foundations, pensions, investment consultants, and financial institutions, facilitating better management of post-investment operations, monitoring, and reporting. By streamlining the data management process, Canoe helps minimize manual data entry and enhances the accuracy of financial reporting and analysis.
Odaseva
Series C in 2024
Odaseva is a company specializing in data management solutions for large enterprises utilizing Salesforce. It offers a comprehensive cloud-based platform that focuses on data protection, privacy, and governance. The Odaseva Enterprise Data Security Platform is designed to ensure the confidentiality, integrity, and availability of critical business information by providing integrated security products and services. Key features of the platform include backup and recovery, archiving, monitoring of governor limits, and compliance support for regulations such as GDPR. By enabling businesses to take full control of their data, Odaseva helps eliminate risks and facilitates confident digital transformation.
Fibe
Secondary Market in 2024
Fibe is an Indian consumer lending platform and app that serves young, aspirational, tech-savvy borrowers. It offers a range of financing options, including cash and personal loans, loans against mutual funds, salary advances, educational, medical, and solar loans, and credit cards. The platform provides tools such as credit scores, financial wellness resources, and loan eligibility calculators to help customers plan and access financing during crunch times.
Fibe
Series E in 2024
Fibe is an Indian consumer lending platform and app that serves young, aspirational, tech-savvy borrowers. It offers a range of financing options, including cash and personal loans, loans against mutual funds, salary advances, educational, medical, and solar loans, and credit cards. The platform provides tools such as credit scores, financial wellness resources, and loan eligibility calculators to help customers plan and access financing during crunch times.
Arnatar Therapeutics
Series A in 2024
Arnatar Therapeutics is a biopharmaceutical company focused on developing novel nucleic acid medications. It specializes in programmable RNA therapeutics for precision therapies targeting liver and extrahepatic metabolic and rare diseases, aiming to restore protein function and provide long-term disease control.
Pelago
Series C in 2024
Pelago specializes in virtual substance use management, empowering members to overcome addiction, primarily tobacco, alcohol, or opioids. It offers cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs, delivered via an accessible platform that integrates with health plans and wellness platforms.
Engrail Therapeutics
Series B in 2024
Founded in 2019, Engrail Therapeutics is dedicated to developing and commercializing neuro drugs. Its primary focus is on treating diseases related to the nervous system. The company's flagship compound, ENX-101, is a preclinical modulator of a receptor for GABA, a neurotransmitter in the brain.
HiLabs
Series B in 2024
HiLabs is a developer of a healthcare data mining platform that aims to enhance data-driven decision-making within healthcare organizations. By leveraging artificial intelligence, HiLabs empowers employees to explore their data intuitively, uncover novel insights, and interact with data visualizations. The platform allows users to customize dashboards and generate new attributes, thus enhancing their ability to understand and utilize client health data effectively. HiLabs recognizes that healthcare providers possess vital domain knowledge but often lack the necessary tools to extract meaningful insights from their data. Through its innovative solutions, HiLabs bridges this gap, enabling healthcare organizations to harness their data more efficiently and improve overall decision-making processes.
Shadowfax
Series E in 2024
Shadowfax is an on-demand logistics network that specializes in providing tech-enabled delivery solutions across various sectors, including e-commerce, food, pharmacy, and consumer goods. By leveraging its unique app, the company offers a reliable last-mile delivery service, allowing businesses to concentrate on their core operations while outsourcing their delivery needs. Shadowfax aims to enhance the customer experience through efficient, fast, and dependable delivery options. Its platform serves both online and offline retailers, catering to the diverse logistics demands of merchants and ensuring timely service. The company envisions establishing itself as a trustworthy and desirable delivery platform, emphasizing the use of advanced technology to streamline logistics and improve customer satisfaction.
EurekaBio
Series B in 2024
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.
Newmo
Seed Round in 2024
Newmo is a technology company that specializes in sustainable local public transportation. It develops a ride-sharing service platform, enabling drivers to work flexibly using their free time, and providing passengers with a safe, secure, and comfortable user experience.
OpenLogi
Series D in 2024
Founded in Tokyo in 2013 by Hidetsugu Ito, OpenLogi designs a cloud-based platform offering affordable outsourced logistics solutions for small and medium-sized enterprises (SMEs) and freelancers. The platform optimizes warehouse control systems, leveraging unused assets and downtime to facilitate efficient logistics operations.
La Fourche
Series B in 2024
La Fourche is an online platform dedicated to affordable organic consumption. It offers thousands of organic products with discounts up to 50%, helping families reduce their spending by up to €1,000 annually through a subscription model.
Xbit
Venture Round in 2024
Xbit is a developer of a shift management system that provides an innovative chatbot service for shop owners. This platform enables businesses to efficiently gather employee availability and create effective shift schedules. By addressing customer issues and needs, Xbit implements tailored solutions that enhance operational efficiency. The company focuses on optimizing business processes, allowing clients to reduce costs while maintaining high service quality through proper personnel allocation.
MakeO
Series D in 2024
MakeO develops an at-home oral and skin care platform that enables customers to achieve their desired smile and complexion. The platform offers at-home solutions for teeth straightening and whitening and for skin rejuvenation, including invisible aligners, laser hair removal, and clinically formulated skincare products.
Everheal
Venture Round in 2024
Everheal is a health technology company focused on supporting women throughout their pregnancy journey, from pre-conception to postpartum. It offers an all-in-one platform for gynecologists to enhance clinical outcomes and generate revenue through patient support features such as nutrition tracking, video consultations, automated vital sign monitoring, and an e-store.
Eon
Seed Round in 2024
Eon is a technology company specializing in enterprise backup and recovery solutions. It offers a cloud-based platform that automatically maps and classifies data, ensuring only critical information is stored. The platform enhances operational efficiency by managing and securing backups, identifying and mitigating data storage risks, and prioritizing essential data for storage.
Micoworks
Series B in 2023
Micoworks is a marketing tool that facilitates communication and optimizes the customer experience through personalization.
PlasmaGen Biosciences
Venture Round in 2023
PlasmaGen Biosciences Pvt. Ltd., established in 2010 and based in Bengaluru, India, is a biopharmaceutical company specializing in plasma protein therapies. The company manufactures a range of products including PlasmaGlob and AlbuMax, brands of Normal Human Immunoglobulin for Intravenous use, PlasmaRho-D I.V. for Rh immunization suppression, PlasmaRAB for rabies infection prophylaxis, PlasmaHep for hepatitis B exposure, VerBumin for conditions like hypovolemic shock and burns, and Gammafact-VIII. These products cater to various medical fields such as hematology, oncology, immunology, pediatrics, rheumatology, dermatology, and neurology. The company serves clinicians, medical practitioners, corporate hospitals, and government institutions.
Exponent Energy
Series B in 2023
Exponent Energy is a start-up dedicated to enhancing electric vehicle (EV) charging through innovative fast charging technology. The company specializes in battery-swapping infrastructure, aiming to provide a more efficient and cost-effective charging solution for EV users. It manufactures an integrated energy stack designed to minimize impedance build-up, which facilitates a smooth energy flow. This system includes a cohesive battery management system, battery pack, and charger that work in unison to streamline the charging process. By focusing on these advancements, Exponent Energy seeks to simplify and accelerate the energy replenishment for electric vehicles, catering to the growing demand for sustainable transportation solutions.
Shinobi Therapeutics
Series A in 2023
Shinobi Therapeutics is a biotechnology company dedicated to developing innovative cell therapies that utilize hypoimmune CD8αβ induced pluripotent stem cells (iPS-T cells) to enhance cancer treatment and address other diseases. The company's advanced immune evasion technology aims to improve the effectiveness and accessibility of these therapies, ultimately reducing costs and enhancing patient outcomes. By focusing on durable responses and the potential for redosing, Shinobi Therapeutics strives to provide the healthcare industry with comprehensive immune therapies that can address a range of diseases, including cancer and genetic disorders.
Eleos Health
Series B in 2023
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.
Sonosemi Medical
Series B in 2023
Sonosemi Medical is a provider of medical devices that specializes in the development of pan-vascular active interventional products, diagnosis, and treatment solutions.
La Fourche
Series B in 2023
La Fourche is an online platform dedicated to affordable organic consumption. It offers thousands of organic products with discounts up to 50%, helping families reduce their spending by up to €1,000 annually through a subscription model.
AlphaGen Therapeutics
Seed Round in 2023
AlphaGen Therapeutics is a biotechnology company specializing in the development and provision of radiopharmaceutical products for cancer treatments. Its core focus is on innovative radioligand therapies, utilizing alpha nuclide radiopharmaceuticals, with additional drugs in early clinical trials. The company aims to deliver innovative radiotherapy solutions to patients, leveraging its cutting-edge technology.
Pixocial
Series A in 2023
Pixocial is a software company specializing in AI-powered photo and video editing solutions. It caters to a wide range of clients, from individual creators and small businesses to large enterprises, offering tools for portrait editing, campaign-driven effects, AR-powered content, and web and desktop toolkits for social media content generation. The company's platform also fosters a creative community, providing global users with advanced editing capabilities and resources to produce and manage digital images and videos.
ScyllaDB
Series C in 2023
ScyllaDB is a company specializing in the development of high-performance, scalable column store database software, particularly suited for data-intensive applications. It offers both open-source and enterprise versions of its product, which can be deployed in various environments, alongside ScyllaDB Cloud, a fully-managed Database as a Service available on major cloud platforms like AWS and Google Cloud. The software is designed to support wide-column NoSQL workloads and is fully compatible with popular systems such as Apache Cassandra and Amazon DynamoDB. Founded as Cloudius Systems, ScyllaDB is based in Herzliya, Israel, and aims to deliver exceptional performance and low latency while reducing costs, enabling organizations to leverage modern multi-core servers effectively as their data needs evolve.
Doceree
Series B in 2023
Doceree is a healthcare marketing technology company that provides a platform and solutions to help pharmaceutical and healthcare brands reach healthcare professionals. Its programmatic platform supports physician engagement and targeted advertising across physician networks, medical journals, telemedicine platforms, and relevant digital channels, delivering compliant, scalable messages. The platform uses artificial intelligence, data segmentation, and analytics to identify target healthcare professionals and optimize reach across global digital ecosystems. Doceree serves pharmaceutical brands, medical device brands, consumer health brands, hospitals, and media agencies, enabling access to physician-only environments and enabling compliant engagement at scale.
Cataya Bio
Series B in 2023
Cataya Bio (Shanghai) Co., Ltd. is a biotechnology company focused on developing synthetic biological products for various industries. Utilizing an advanced engineering biology platform, Cataya Bio engineers microbes and implements clean fermentation processes to produce high-purity products efficiently and sustainably. The company aims to facilitate the transition from petroleum-based materials to natural and sustainable raw materials, addressing critical global challenges such as environmental preservation, carbon emissions, and climate change. Through its innovative approach, Cataya Bio provides clients with effective solutions for sourcing raw materials that align with contemporary sustainability goals.
New Vision Medical
Series A in 2023
New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
Tenpoint Therapeutics
Series A in 2023
Tenpoint Therapeutics is a biotechnology company dedicated to developing engineered cell-based therapies aimed at restoring vision for individuals affected by degenerative ocular diseases. The company leverages an innovative platform that includes in vivo reprogramming techniques, allowing for targeted delivery of therapeutic systems directly to the eye. This approach eliminates the need for systemic administration, which can improve treatment efficacy and patient outcomes. By focusing on vision restoration, Tenpoint Therapeutics strives to significantly enhance the quality of life for patients suffering from various eye conditions.
Raft
Series B in 2023
Raft is a smart logistics platform focused on automating the freight process to enhance control and visibility in logistics operations. It leverages artificial intelligence to analyze and act on incoming shipment data, significantly reducing the time operators spend on information retrieval and manual data entry. By automating various tasks, including accounts payable invoices, customs documentation, and shipping workflows, Raft enables freight forwarders and customs brokers to minimize manual work, thus improving accuracy and compliance. The platform's real-time processing capabilities further allow operators to manage shipments more efficiently, ensuring timely and reliable service for their customers.
Chian Technology
Venture Round in 2023
Chian Technology is a developer of a network security system. The company's product line includes standardized zero-trust products as well as customized zero-trust solutions based on the personalized circumstances of various customers, allowing users to obtain multi-faceted network security protection. Their products are used in fields such as the Internet, finance, energy, technology, high-end manufacturing, new retail, and others.
K36 Therapeutics
Series B in 2023
K36 Therapeutics develops small molecule therapeutics for cancer treatment. It translates epigenetic modulation of oncogenic pathways into small molecule therapies.
BTP Automation
Grant in 2023
BTP Automation provides a hotel sourcing platform and analytics for corporate travel programs. The company collects and analyzes booking and hotel data from multiple sources to generate automated cost savings and to provide insights into hotel attachment rates. Its platform supports corporate travel program management by gathering booking details, applying machine learning for instant adjustments, and streamlining contract term negotiations across the hotel program lifecycle. This enables travel managers to achieve measurable cost reductions while reducing administrative effort and maintaining transparency on policy compliance and accommodation spend.
Adcentrx Therapeutics
Series A in 2023
Adcentrx Therapeutics is a biotechnology company focused on protein conjugate therapeutics for cancer and other life-threatening diseases. The company seeks to accelerate breakthroughs in this field by combining the targeting precision of biologics with the potency of small-molecule payloads, enabling next-generation targeted therapies and expanding treatment options for patients.
SAFE Security
Series B in 2023
SAFE Security, also known as Lucideus Tech Private Limited, is a cyber risk management company headquartered in New Delhi, India. Founded in 2012, it specializes in providing comprehensive information technology risk assessment and digital security services to organizations globally. The company develops a cyber risk quantification and management platform that enables businesses to continuously monitor and respond to cyber threats in real time. SAFE Security's offerings include IT security maturity assessments, governance policy formation, application security, IT infrastructure security, and emergency response services. By establishing a common risk taxonomy, the platform facilitates better communication among stakeholders and shifts the focus of security discussions from tactical projects to strategic value, ultimately helping organizations mitigate cyber risks through prioritized actionable insights.
Aden Financial Group
Series A in 2023
Aden Financial Group operates a cross-border over-the-counter (OTC) assets e-trading platform focused on facilitating trades denominated in Chinese renminbi. The platform provides a comprehensive suite of services that includes alternative data display, price discovery, automatic trade-matching, and click-to-trade functionalities. This enables international investors, including ultra-high-net-worth individuals, family offices, and funds, to access and invest in the Greater Chinese markets and assets efficiently.
Lanzhou Technology
Seed Round in 2023
Lanzhou cognitive intelligence platform is an industrial service cloud platform with NLP as the core, providing a series of services such as a graph, machine translation, assisted writing, sentiment analysis, intelligent retrieval, intelligent customer service, document analysis, etc. Enter search, generation, translation, dialogue, and other business scenarios. They provide solutions for financial, marketing, cultural, and creative industries, focusing on the core scenarios in the industry to provide solutions to help enterprises upgrade intelligently.
TandemAI
Series A in 2023
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.
Canoe
Series B in 2023
Canoe Software Inc. provides a sophisticated software solution focused on financial document and data management. Founded in 2013 and based in New York, the company specializes in automating the extraction and organization of investment documents using artificial intelligence and machine learning technologies. This enables users to efficiently convert unstructured data from various formats, such as PDFs, into actionable insights, thereby improving operational efficiency. Canoe's platform supports a wide range of clients, including single and multi-family offices, endowments, foundations, pensions, investment consultants, and financial institutions, facilitating better management of post-investment operations, monitoring, and reporting. By streamlining the data management process, Canoe helps minimize manual data entry and enhances the accuracy of financial reporting and analysis.
NOCD
Series B in 2023
NOCD Inc. is a Chicago-based company founded in 2014 that specializes in developing a mobile application aimed at assisting individuals with obsessive-compulsive disorder (OCD). The platform connects users to licensed therapists who specialize in OCD through face-to-face video therapy sessions. Utilizing cognitive behavioral therapy techniques, the application guides users in self-treatment and monitoring of their symptoms, offering tools for exposure and response prevention exercises. In addition to therapy sessions, NOCD provides 24/7 support via self-help resources and peer communities, facilitating ongoing care and enabling patients to manage their condition effectively. The company focuses on improving treatment outcomes for OCD through its innovative online platform.
Enko Chem
Series C in 2023
Enko Chem, Inc., established in 2017 and based in Woburn, Massachusetts, specializes in the discovery and development of small-molecule and novel products designed to protect crops from pests and diseases. The company's proprietary technology platform enables it to swiftly identify safe and cost-effective solutions, contributing to sustainable food production.
Enzene Biosciences
Venture Round in 2023
Enzene Biosciences develops cost-effective biosimilars through advanced analytics and state-of-the-art manufacturing. It aims to provide affordable medicines swiftly, utilizing good manufacturing practices (GMP) processes.
Cloudian
Venture Round in 2023
Cloudian is a company that specializes in file and object storage, particularly focusing on S3 object storage within data centers. It offers a hybrid cloud data management platform that allows customers to optimize data access, meet data sovereignty requirements, and reduce costs by consolidating information into a single, cloud-like environment. Cloudian's platform provides scalable and secure object storage for hybrid cloud deployments, enabling organizations to effectively manage and protect their data both on-premises and in the cloud. With its emphasis on data durability and user-friendly management tools, Cloudian aims to transform enterprise data into actionable insights while ensuring compatibility with the industry-standard S3 API.
Coho AI
Seed Round in 2023
Coho AI is a company that provides a product-led revenue platform designed to enhance the effectiveness of growth, customer success, and sales teams. Founded in 2021 and based in New York, the company leverages artificial intelligence to integrate with existing B2B SaaS tools, offering a comprehensive analysis of user interactions with products. This platform empowers businesses to make informed decisions based on user behavior data, facilitating increased upsells, expansions, and self-service conversions. By focusing on the right revenue opportunities, Coho AI aims to help teams improve conversion rates and deliver greater value to users.
MEIHUAMEDICAL
Series B in 2022
MEIHUAMEDICAL develops, produces and sells microbial medical instruments & diagnostic reagents.
Alternative Bio
Seed Round in 2022
Alternative Bio is a biotechnology company focused on developing novel therapeutics targeting a previously untapped class of post-translational modifying enzymes.
RedPine Medical
Series C in 2022
RedPine Medical, founded in 2015 and headquartered in Guangzhou, China, specializes in the manufacture of single-use medical endoscopes. The company focuses on providing advanced minimally invasive surgical devices for various applications, including urology, gynecology, ear, nose, and throat (ENT), pneumology, gastroenterology, and general surgeries. By emphasizing innovative solutions, RedPine aims to enhance detection, diagnosis, and treatment in medical settings, positioning itself as a global leader in the field of integrated minimally invasive surgical solutions.
ABK Biomedical
Series C in 2022
Founded in 2012, ABK Biomedical specializes in developing embolotherapeutic products for treating hypervascular tumors. Its primary focus is improving treatment options for patients through innovative microsphere technology.
Ruiyun Cold Chain
Seed Round in 2022
Ruiyun Cold Chain is a logistics service platform in China that specializes in cold chain transportation. Utilizing innovative domestic technology, the company offers comprehensive, digital, end-to-end cold chain integration services. Its proprietary platform, which includes Lengyunbao, a unique carrier-type online trading system, facilitates a seamless online experience for transactions, delivery, settlement, and tax collection. By fostering interaction and collaboration within a social cold chain network, Ruiyun Cold Chain effectively links industry resources with customer demand, helping businesses optimize operational efficiency and achieve significant reductions in logistics costs, typically between 10% and 15%.
Red Points
Venture Round in 2022
Red Points is a technology company based in Barcelona, Spain, that specializes in online brand protection. Founded in 2011, the company offers a software-as-a-service platform designed to combat online counterfeiting, digital piracy, and distribution fraud. Utilizing advanced machine learning and computer vision techniques, Red Points' software effectively detects and removes counterfeit goods and pirated content from the internet. The platform operates across more than one hundred online marketplaces and social networks, addressing hundreds of thousands of incidents each month. With a client base that includes over five hundred brands worldwide, such as Bang & Olufsen, MVMT, and DOPE, Red Points provides essential solutions for brands and content owners seeking to safeguard their intellectual property rights in the digital landscape.
Cataya Bio
Series A in 2022
Cataya Bio (Shanghai) Co., Ltd. is a biotechnology company focused on developing synthetic biological products for various industries. Utilizing an advanced engineering biology platform, Cataya Bio engineers microbes and implements clean fermentation processes to produce high-purity products efficiently and sustainably. The company aims to facilitate the transition from petroleum-based materials to natural and sustainable raw materials, addressing critical global challenges such as environmental preservation, carbon emissions, and climate change. Through its innovative approach, Cataya Bio provides clients with effective solutions for sourcing raw materials that align with contemporary sustainability goals.
Elucidata
Series A in 2022
Elucidata Corporation, established in 2015 and based in New Delhi, India, specializes in accelerating drug discovery by translating phenotypic screenings into therapeutic strategies. The company's core offering is Polly, a proprietary SaaS platform that transforms drug discovery through curated biomedical molecular data. Polly hosts over 230,000 multi-omic datasets, with around 50,000 new datasets added monthly, and offers exclusive access to curated data ready for machine learning workflows. This platform enables 10x faster identification of therapeutic assets and has facilitated the detection of multiple validated drug targets across immunology, oncology, and metabolomic disorders. Polly supports discovery programs at prominent biopharma companies such as Pfizer, Agios Pharmaceuticals, Genentech, and Yale, with over 35 research partners from premier institutions.
Bhanzu
Series A in 2022
Bhanzu is a learning platform focused on mathematics education. It caters to students of all ages and grades, offering personalized learning experiences tailored to individual needs. The platform aims to foster careers in math and STEM fields by providing engaging educational content, including videos with tips on overcoming math anxiety for young learners.
Qixiangyun
Seed Round in 2022
Qixiangyun is a pioneering enterprise in China that specializes in developing an open platform for financial and taxation standard components. The company focuses on empowering independent software vendors (ISVs) by providing high-quality, standardized financial and taxation technology services tailored for terminal enterprises. Its platform features an intelligent financial and tax report accounting engine at its core, offering APIs and configurable functional modules that can seamlessly integrate with various enterprise software systems. This integration facilitates efficient digital transformation across business, finance, and taxation sectors. Additionally, Qixiangyun aims to streamline the national tax declaration process, enabling multi-enterprise and cross-regional one-click tax declaration and deduction, significantly enhancing the operational capabilities of enterprises in the digital age.
InsightFinder
Series A in 2022
InsightFinder is a technology company that provides AI-powered observability and IT management solutions. It offers unsupervised machine‑learning based anomaly detection, root-cause analysis, and incident prediction to automatically identify, diagnose, and remediate issues across applications and infrastructure. The platform delivers real-time log analysis, metric intelligence, and alert management to reduce noise and alert fatigue while helping IT teams prevent outages and optimize performance. Its solutions are designed for enterprise-scale environments, enabling proactive maintenance for homegrown and third‑party applications and services. Headquartered in Brooklyn, New York, InsightFinder serves organizations seeking predictive analytics and automated troubleshooting to improve reliability and efficiency in complex IT ecosystems.
StashAway
Series D in 2022
StashAway Malaysia Sdn Bhd is a licensed investment platform in Malaysia that specializes in wealth management and portfolio management for both retail and accredited investors. The company is dedicated to providing accessible investment solutions, emphasizing low fees and personalized financial planning. StashAway's platform caters to a diverse audience by offering tools and resources that facilitate informed investment decisions. Its innovative investment strategy, ERAA® (Economic Regime-based Asset Allocation), aims to maximize long-term returns while managing individual risk exposure in response to changing economic conditions. Through its user-friendly mobile app, StashAway simplifies the investment process, making wealth management more approachable for a broad range of investors.
Jade Bird Display
Series A in 2022
Jade Bird Display (Shanghai) Limited is a manufacturer based in Shanghai, China, specializing in the development and production of micro-LED display chips and panels. Founded in 2015, the company focuses on research and development to create the smallest, brightest, and most efficient micro-display solutions. Its products are designed for various applications, including augmented reality (AR), virtual reality (VR), head-up displays (HUD), projectors, weapon sights, 3D printing, and microscopes. By providing ultra-compact micro-display panels, Jade Bird Display enables original equipment manufacturers to enhance user experience in AR and VR hardware, offering improved comfort, outdoor readability, and extended operating times between charges. The company also maintains an office in Hong Kong to support its operations.
Lingtan Intelligent Technology
Seed Round in 2022
Lingtan Intelligent Technology specializes in the development of innovative and sustainable distributed energy storage products and services. The company is dedicated to researching and developing hardware and software for energy storage systems, as well as virtual power plant trading platforms. Lingtan aims to provide energy storage-based solutions tailored for various industrial and commercial markets, including factories, commercial buildings, charging stations, and data centers. Through its focus on advanced technology, the company seeks to enhance energy efficiency and sustainability across multiple sectors.
Enko Chem
Series C in 2022
Enko Chem, Inc., established in 2017 and based in Woburn, Massachusetts, specializes in the discovery and development of small-molecule and novel products designed to protect crops from pests and diseases. The company's proprietary technology platform enables it to swiftly identify safe and cost-effective solutions, contributing to sustainable food production.
Asobica
Venture Round in 2022
Asobica, Inc. is a Japanese company based in Shinagawa that focuses on the planning, development, and management of Internet-based businesses. The company aims to revitalize traditional industries through innovative technology and community engagement. Its flagship product, fever, serves as a platform for issuing community coins, fostering active participation within user communities. Asobica's software suite includes tools for customer relationship management, customer analysis, and community coin issuance, all designed to enhance user engagement and loyalty. By leveraging these technologies, Asobica seeks to support sustainable corporate growth and improve customer retention for its clients.
ProcessOn
Series A in 2022
ProcessOn is a developer of online diagramming and collaboration tools that facilitate the creation of flowcharts, mind maps, BPMN, UML diagrams, and more. The platform serves as a social network for business processes, enabling users to collaborate in real-time on diagram creation and sharing. This functionality allows teams to visualize complex ideas and processes collectively, thereby enhancing understanding and retention of abstract concepts. In addition to its primary mapping tool, ProcessOn offers Little Drawing Table, a visual collaboration whiteboard software that supports brainstorming and client discussions on a single digital canvas. This dual approach not only provides mapping capabilities but also fosters a community where users can share knowledge and access a diverse database of diagrams.
Kaiko
Series B in 2022
Kaiko is a leading provider of cryptocurrency market data, offering global connectivity to over 100 centralized and decentralized exchanges. It bridges traditional finance with crypto by delivering actionable financial data through its Market Data, Quantitative Analytics, Indices, and Research units.
Gloat
Series D in 2022
Gloat is an innovative Internal Talent Marketplace that empowers organizations to unlock and utilize the hidden potential of their workforce. Through its AI-driven platform, Gloat matches employees' skills and aspirations with suitable internal career opportunities, fostering personalized career development in real time while maintaining user anonymity. This approach not only supports individual career growth but also enhances organizational agility and visibility. Gloat is utilized by prominent companies around the globe, with deployments in over 120 countries, including major brands such as Unilever, PepsiCo, and HSBC. By providing valuable insights and data-driven recommendations, Gloat enables individuals to make informed career decisions and helps managers identify the right candidates for various roles within their organizations.
Changjin Biotechnology
Series A in 2022
Developer of edible microbial synthetic protein food intended to provide new form of protein sources. The company focuses on the research, development and industrialization of new microbial proteins and biosynthetic proteins, enabling clients with safe, nutritious and delicious microbial substitute protein artificial food, while lowering carbon emissions.
Spry
Series A in 2022
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.
EurekaBio
Series B in 2022
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.
Immuneel Therapeutics
Series A in 2022
Immuneel Therapeutics specializes in developing innovative cell and gene therapies for cancer treatment. The company focuses on CAR-T cell therapies, which are created by extracting blood cells from patients and genetically engineering healthy immune cells to specifically target malignant cells. This approach allows cancer patients to benefit from advanced cell-based immunotherapies that have the potential to transform their treatment outcomes.
Proximie
Series C in 2022
Proximie is a health technology company that enables surgeons worldwide to collaborate remotely using augmented reality, artificial intelligence, and machine learning. Its platform allows surgeons to visually guide complex surgeries, democratizing access to advanced surgical knowledge.
MoEngage
Series E in 2022
MoEngage, Inc. is a technology company that provides a cloud-based user analytics and engagement platform aimed at enhancing customer retention and lifetime value for consumer businesses. Founded in 2014 and headquartered in San Francisco, California, the company serves various industries, including e-commerce, telecommunications, travel and hospitality, and banking and finance. MoEngage's platform enables businesses to deliver personalized interactions through multiple channels, such as push notifications, in-app messaging, web push, and SMS, all managed from a single dashboard. With a focus on machine learning, the platform optimizes customer engagement by analyzing user behavior and delivering tailored recommendations. MoEngage also has offices in several international locations, including Bengaluru, Singapore, London, Jakarta, Bangkok, Ho Chi Minh City, and Berlin.
Quantstamp
Series A in 2022
Quantstamp is a blockchain security company that provides scalable security audits and related services to developers and blockchain projects. Founded in 2017 and based in Dover, Delaware, it focuses on ensuring the reliability and integrity of blockchain ecosystems through smart contract audits, protocol testing, vulnerability assessments, security monitoring, and insurance products. The firm serves decentralized finance and gaming sectors to protect digital assets, support compliance with industry standards, and foster user trust.
Wint Wealth
Series A in 2022
Founded in 2020 and based in Bengaluru, Wint Wealth offers asset-backed fixed income products to high net-worth individuals and retail investors. These products aim to provide higher returns than traditional fixed deposits with minimum investments starting as low as Rs. 10,000.
BlissClub
Series A in 2022
BlissClub is a pioneering women's activewear brand focused on creating comfortable and functional apparel specifically for Indian women. The company designs products such as leggings and sports bras, addressing prevalent challenges in women's activewear related to fabric, fit, and function. By prioritizing a community-driven approach, BlissClub aims to empower women to find suitable sportswear that meets their needs, while also providing the convenience of home delivery.
Invetx
Series B in 2022
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.
Toothsi
Series C in 2022
Toothsi is a dental company that offers clear aligners, an alternative to traditional braces, to gradually shift teeth into proper alignment. Toothsi's aligners are removable, invisible, and more comfortable than metal braces. Toothsi also provides oral hygiene products, teeth whitening solutions, and aligner accessories for complete oral care.
Reveal
Series A in 2022
Reveal, formerly known as Sharework, is the free platform for Partnership, Marketing, and Sales teams to generate revenue through their ecosystem.
Reveal allows you to connect with companies from your ecosystem, securely compare your CRM data, and multiply up to 3X your win rate thanks to your ecosystem’s insights.
Worktile Technology
Series C in 2022
Worktile Technology, established in 2013, is a Chinese software company headquartered in Beijing, with offices in Shanghai, Shenzhen, and Xi'an. It specializes in a web and mobile-based project management tool, designed to enhance team collaboration and productivity among developers and professionals. The platform facilitates task management, communication, and document sharing, aiming to streamline work processes and improve overall enterprise efficiency.
Noogata
Series A in 2022
Noogata is an AI-powered eCommerce platform that provides insights and strategic guidance to consumer brands, digital brands, and agencies to accelerate online growth. The platform aggregates and analyzes competitive data, consumer search behavior, and market signals, enabling users to visualize, measure, and act on insights with an AI growth assistant. It monitors thousands of products and categories to deliver actionable guidance on competitive positioning, pricing, advertising, and assortment, helping brands improve digital shelf performance and outperform competitors across online marketplaces including Amazon. The solution is enterprise-grade and offered as SaaS, designed to streamline competitive intelligence for ecommerce teams.
Doceree
Series A in 2022
Doceree is a healthcare marketing technology company that provides a platform and solutions to help pharmaceutical and healthcare brands reach healthcare professionals. Its programmatic platform supports physician engagement and targeted advertising across physician networks, medical journals, telemedicine platforms, and relevant digital channels, delivering compliant, scalable messages. The platform uses artificial intelligence, data segmentation, and analytics to identify target healthcare professionals and optimize reach across global digital ecosystems. Doceree serves pharmaceutical brands, medical device brands, consumer health brands, hospitals, and media agencies, enabling access to physician-only environments and enabling compliant engagement at scale.
Amenitiz
Series A in 2022
Amenitiz develops an all-in-one operating platform for independent hoteliers and vacation-property owners. The system centralizes essential tools to run properties, including building conversion-optimized websites, attracting guests, and managing bookings, with the goal of making operations simple, profitable, and hassle-free. By unifying website creation, guest acquisition, and reservation management, the platform supports property owners in growing occupancy and improving guest experiences across diverse locations. Amenitiz emphasizes accessible online hospitality, providing a single solution designed to streamline workflows, optimize performance, and reduce manual tasks for small-to-mid-scale operators.
Eleos Health
Series A in 2022
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.
ekincare
Series B in 2022
ekincare is an AI-powered integrated health benefits platform that provides personalized healthcare solutions for organizations and employees. It offers a range of services including online consultations, health check-ups, medicine delivery, wellness programs, and fitness services.
Tibber
Series C in 2022
Founded in Norway and Sweden in 2016, Tibber is a digital electricity supplier offering smart solutions to minimize customers' consumption and costs. It provides renewable energy at fair prices, real-time analytics via its app, and compatibility with various smart home devices. Tibber aims to reduce residential electricity consumption by 20% across Europe.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.